Enhabit to be Acquired by Kinderhook Industries for $1.1 Billion in Cash

Enhabit, Inc. (EHAB) entered a merger agreement on February 23, 2026, to be acquired by Kinderhook Industries, LLC for $1.1 billion.

Deal Structure:

Enhabit stockholders will receive $13.8 per share in cash, representing a premium of 24.44% from the stock’s last close.

Company Profile:

Enhabit is a home health and hospice provider based in Dallas, Texas, delivering comprehensive in-home care and support across 34 states through its network of locations and specialized clinical services.

Kinderhook Industries is a middle‑market private investment firm that has raised over $10 billion of committed capital and makes control investments in healthcare services, environmental and industrial services, and light manufacturing & automotive companies to partner with management and drive growth.

Deal Details and Timeline:

The deal is expected to close in the second quarter of 2026.

Kinderhook has arranged committed financing for the transaction, including debt from certain lenders and equity from funds it manages, enough to cover the purchase price and related closing costs.

Enhabit received financial advice from Goldman Sachs and legal counsel from Jones Day. Kinderhook Industries was advised financially by Guggenheim Securities and legally by Kirkland & Ellis.

Kinderhook’s acquisition price for Enhabit is 0.54 times the sales.

Deal Metrics:

For a more in-depth analysis of this merger and acquisition transaction, please visit the Deal Metrics page here:

Deal Metrics for the acquisition of Enhabit, Inc. (EHAB) by Kinderhook Industries, LLC

The comprehensive Deal Metrics page for each merger or acquisition provides:

• A spread history chart tracking the merger from announcement through completion or failure.
• Updates on every event as the merger advances through the HSR period, regulatory approvals, shareholder votes, etc.
• Latest news and SEC filings.
• A history of deal updates.
• And much more valuable information.

Disclaimer: This article is not a solicitation to buy or sell securities. Please conduct your own thorough research before making any investment decisions. We do not warrant the completeness or accuracy of the content or data provided in this article.

Editor’s Note: Baranjot Kaur contributed to this article